| Literature DB >> 35619640 |
Eric J Cooks1, Kyle A Duke2, Jordan M Neil3, Melissa J Vilaro1, Danyell Wilson-Howard4, Francois Modave5, Thomas J George6, Folakemi T Odedina7, Benjamin C Lok8, Peter Carek9, Eric B Laber10, Marie Davidian2, Janice L Krieger1.
Abstract
Introduction: Racial disparities in colorectal cancer (CRC) can be addressed through increased adherence to screening guidelines. In real-life encounters, patients may be more willing to follow screening recommendations delivered by a race concordant clinician. The growth of telehealth to deliver care provides an opportunity to explore whether these effects translate to a virtual setting. The primary purpose of this pilot study is to explore the relationships between virtual clinician (VC) characteristics and CRC screening intentions after engagement with a telehealth intervention leveraging technology to deliver tailored CRC prevention messaging.Entities:
Keywords: Cancer health disparities; colorectal cancer screening; precision prevention; telehealth; virtual human technology
Year: 2022 PMID: 35619640 PMCID: PMC9108377 DOI: 10.1017/cts.2022.386
Source DB: PubMed Journal: J Clin Transl Sci ISSN: 2059-8661
Fig. 1.Images of the Meet ALEX (Agent Leveraging Empathy for eXams) virtual clinicians.
Sociodemographic characteristics of participants (N = 2267)
| Characteristic |
|
|---|---|
| Age, mean (SD) | 58.7 (6.2) |
| Gender, No. (%) | |
| Man | 908 (40.1%) |
| Woman | 1359 (59.9%) |
| Race, No. (%) | |
| Black | 840 (37.1%) |
| White | 1427 (62.9%) |
| Education | |
| College graduate | 475 (22.8%) |
| Technical, trade or vocational school AFTER high school | 559 (26.9%) |
| High school incomplete (completed grades 1–8) | 41 (2.0%) |
| Post-graduate training/professional school after college (M.A., Ph.D., JD, or MD) | 195 (9.4%) |
| Some college | 809 (38.9%) |
| Income | |
| Less than $10,000 | 142 (6.8%) |
| $10–$20,000 | 298 (14.3%) |
| $20–$30,000 | 338 (16.3%) |
| $30–$40,000 | 246 (11.8%) |
| $40–$50,000 | 198 (9.5%) |
| $50–$75,000 | 336 (16.2%) |
| $75–$100,000 | 204 (9.8%) |
| $100,000 or more | 158 (7.6%) |
Proportion of participant responses across items, overall and by race
| Study variable | Overall % ( | Participant race % ( | |
|---|---|---|---|
| Black | White | ||
|
| |||
| 1 | 0.4 (9) | 0.2 (1) | 0.06 (8) |
| 2 | 0.3 (6) | 0.3 (2) | 0.03 (4) |
| 3 | 6.7 (139) | 4.4 (28) | 7.8 (111) |
| 4 | 25.4 (523) | 17.0 (109) | 29.1 (414) |
| 5 | 67.2 (1386) | 78.2 (502) | 62.2 (884) |
|
| |||
| 1 | 1.9 (40) | 1.5 (10) | 2.1 (30) |
| 2 | 2.9 (60) | 2.0 (13) | 3.3 (47) |
| 3 | 43.0 (889) | 34.1 (220) | 47.0 (669) |
| 4 | 25.0 (516) | 24.1 (156) | 25.3 (360) |
| 5 | 27.2 (563) | 38.2 (247) | 22.2 (316) |
|
| |||
| 1 | 7.5 (156) | 6.7 (44) | 7.8 (112) |
| 2 | 12.1 (251) | 9.8 (64) | 13.1 (187) |
| 3 | 29.1 (606) | 24.2 (158) | 31.4 (448) |
| 4 | 27.5 (571) | 26.2 (171) | 28.0 (400) |
| 5 | 23.8 (495) | 33.0 (215) | 19.6 (280) |
|
| |||
| 1 | 9.0 (188) | 5.4 (35) | 10.7 (153) |
| 2 | 7.6 (157) | 5.4 (35) | 8.5 (122) |
| 3 | 21.2 (441) | 16.4 (107) | 23.4 (334) |
| 4 | 25.5 (531) | 22.4 (146) | 27.0 (385) |
| 5 | 36.7 (762) | 50.5 (329) | 30.3 (433) |
Abbreviation: VC, virtual clinician. CRC, colorectal cancer.
Proportion of participant responses across items, overall and by participant race/virtual clinician (VC) race-matching
| Study variable | Overall % ( | Participant race/race-matching % ( | |||
|---|---|---|---|---|---|
| Black/matched | Black/mis-matched | White/matched | White/mis-matched | ||
|
| |||||
| 1 | 0.4 (9) | 0.0 (0) | 0.3 (1) | 1.3 (7) | 0.1 (1) |
| 2 | 0.3 (6) | 0.2 (1) | 0.3(1) | 0.6 (3) | 0.1 (1) |
| 3 | 6.7 (139) | 3.8 (17) | 2.8 (11) | 9.1 (43) | 7.6 (68) |
| 4 | 25.4 (523) | 10.8 (48) | 15.4 (61) | 32.9 (175) | 26.7 (239) |
| 5 | 67.2 (1386) | 59.3 (264) | 60.3 (238) | 57.0 (303) | 64.9 (581) |
|
| |||||
| 1 | 1.9 (40) | 0.9 (4) | 1.5 (6) | 3.4 (18) | 1.3 (12) |
| 2 | 2.9 (60) | 1.6 (7) | 1.5 (6) | 3.4 (18) | 3.2 (29) |
| 3 | 43.0 (889) | 22.5 (100) | 30.4 (120) | 52.3 (278) | 43.7 (391) |
| 4 | 25.0 (516) | 17.3 (77) | 20.0 (79) | 25.6 (136) | 25.0 (224) |
| 5 | 27.2 (563) | 32.6 (145) | 25.8 (102) | 15.2 (81) | 26.3 (235) |
|
| |||||
| 1 | 7.5 (156) | 6.5 (29) | 3.8 (15) | 8.3 (44) | 7.6 (68) |
| 2 | 12.1 (251) | 6.1 (27) | 9.4 (37) | 14.5 (77) | 12.3 (110 |
| 3 | 29.1 (606) | 15.1 (67) | 23.0 (91) | 34.2 (182) | 29.7 (266) |
| 4 | 27.5 (571) | 19.6 (87) | 21.3 (84) | 24.2 (129) | 30.3 (271) |
| 5 | 23.8 (495) | 28.3 (126) | 22.5 (89) | 18.8 (100) | 20.1 (180) |
|
| |||||
| 1 | 9.0 (188) | 3.4 (16) | 5.1 (20) | 11.7 (62) | 10.2 (91) |
| 2 | 7.6 (157) | 3.6 (16) | 4.8 (19) | 8.8 (47) | 8.4 (75) |
| 3 | 21.2 (441) | 13.7 (61) | 11.6 (46) | 24.1 (128) | 23.0 (206) |
| 4 | 25.5 (531) | 14.8 (66) | 20.3 (80) | 28.4 (151) | 26.1 (234) |
| 5 | 36.7 (762) | 40.0 (178) | 38.2 (151) | 27.1 (144) | 32.3 (289) |
Abbreviation: VC, virtual clinician. CRC, colorectal cancer.
Regression of participant race, race-matching, and intervention type on virtual clinician (VC) credibility, VC attractiveness, message relevance, and colorectal cancer (CRC) screening intention
| Predictor variable | VC credibility | VC attractiveness | Message relevance | CRC screening intention | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| 95% |
|
| 95% |
|
| 95% |
|
| 95% | |
|
| ||||||||||||
| Age | 0.002 (0.008) | 0.8 | (−0.01, 0.02) | 0.01 (0.01) | 0.41 | (−0.01, 0.02) | −0.03 (0.01) | <0.001 | (−0.04, −0.02) | −0.02 (0.01) | <0.001 | (−0.04, −0.01) |
| Sex (women) | 0.34 (0.10) | <0.001 | (0.15, 0.53) | 0.58 (0.09) | <0.001 | (0.41, 0.75) | 0.25 (0.08) | 0.002 | (0.09, 0.41) | 0.22 (0.08) | 0.009 | (0.05, 0.38) |
|
| ||||||||||||
| Black vs. white participants (ref) | 0.38 (0.18) | 0.04 | (0.03, 0.75) | 0.11 (0.16) | 0.49 | (−0.20, 0.41) | 0.24 (0.15) | 0.11 | (−0.06, 0.54) | 0.53 (0.15) | <0.001 | (0.23, 0.84) |
| Matched vs. not-matched (ref) | −0.25 (0.14) | 0.09 | (−0.53, 0.04) | −0.34 (0.13) | 0.01 | (−0.61, −0.08) | −0.20 (0.13) | 0.12 | (−0.45, 0.05) | −0.17 (0.13) | 0.18 | (−0.42, 0.08) |
| Interactive VC vs. static VC (ref) | 0.45 (0.13) | 0.001 | (0.19, 0.72) | 0.41 (0.12) | <0.001 | (0.18, 0.64) | 0.26 (0.11) | 0.02 | (0.04, 0.48) | 0.14 (0.11) | 0.22 | (−0.08, 0.36) |
|
| ||||||||||||
| VC type × race-matching | −0.14 (0.19) | 0.47 | (−0.51, 0.24) | −0.19 (0.17) | 0.26 | (−0.52, 0.14) | 0.12 (0.16) | 0.45 | (−0.20, 0.44) | 0.11 (0.16) | 0.51 | (−0.21, 0.43) |
| VC type × participant race | 0.16 (0.22) | 0.48 | (−0.28, 0.60) | 0.07 (0.18) | 0.69 | (−0.28, 0.42) | −0.16 (0.17) | 0.35 | (−0.50, 0.18) | 0.02 (0.18) | 0.92 | (−0.32, 0.36) |
| Race-matching × participant race | 0.56 (0.22) | 0.01 | (0.12, 1.00) | 0.93 (0.18) | <0.001 | (0.58, 1.29) | 0.47 (0.18) | 0.01 | (0.13, 0.82) | 0.29 (0.18) | 0.1 | (−0.05, 0.64) |
Abbreviation: VC, virtual clinician. CRC, colorectal cancer.
Regression analyses. All statistical tests were two-sided. B = unstandardized beta-coefficient; CI = confidence interval.
Fig. 2.Interaction effect of participant race and virtual clinician (VC) race-matching on colorectal cancer (CRC) screening intention.
Fig. 3.A conceptual model of parallel mediation depicting the indirect effects of race-matching x participant race through virtual clinician (VC) credibility, VC attractiveness, and perceived message relevance on participant colorectal cancer (CRC) screening intention. Note. Three direct effects of race-matching × participant race on intent are presented, each controlling for the mediator in the regression model (M1, M2, M3); Solid lines represent statistically significant relationships; *P < 0.05; **P < 0.01; **P < 0.001.
Path coefficients from the parallel mediation model illustrated in Fig. 3
| Predictor variable | VC credibility | VC attractiveness | Message relevance | CRC screening intention | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| 95% |
|
|
|
|
| 95% |
|
| 95% | |
|
| ||||||||||||
| Race-matching × participant race | 0.56 (0.22) | 0.01 | (0.12, 1.00) | 0.93 (0.18) | <0.001 | (0.58, 1.29) | 0.47 (0.18) | 0.01 | (0.13, 0.82) | 0.29 (0.18) | 0.10 | (−0.05, 0.64) |
|
| ||||||||||||
| Message relevanceM1 | – | – | – | – | – | – | – | – | – | 0.91 (0.04) | <0.001 | (0.83, 0.99) |
| VC attractivenessM2 | – | – | – | – | – | – | – | – | – | 0.51 (0.05) | <0.001 | (0.42, 0.60) |
| VC source credibilityM3 | – | – | – | – | – | – | – | – | – | 0.92 (0.06) | <0.001 | (0.80, 1.05) |
|
| ||||||||||||
| Race-matching × participant raceM1 | – | – | – | – | – | – | – | – | – | 0.22 (0.19) | 0.25 | (−0.15, 0.58) |
| Race-matching × participant raceM2 | – | – | – | – | – | – | – | – | – | 0.07 (0.18) | 0.70 | (−0.28, 0.43) |
| Race-matching × participant raceM3 | – | – | – | – | – | – | – | – | – | 0.17 (0.18) | 0.34 | (−0.18, 0.53) |
Abbreviation: VC, virtual clinician. CRC, colorectal cancer.
Note: Em-dash represents a relationship that was not regressed upon as part of the model.
Parallel mediation conducted using the ordinal package in R 4.0.1. All statistical tests were two-sided. B = unstandardized beta-coefficient; CI = confidence interval.